REQUEST A DEMO
Total
USD $0.00
Search more companies

Amgen Biotecnologica S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Amgen Biotecnologica S A S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Amgen Biotecnologica S A S is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on September 18, 2013. 123 (2024) employees currently work for Amgen Biotecnologica S A S. From the latest financial highlights, Amgen Biotecnologica S A S reported a net sales revenue increase of 27.5% in 2023. Over the same period, its total assets grew by 23.85%. In 2023, Amgen Biotecnologica S A S’s net profit margin decreased by 0.39%.

Headquarters
Carrera 7 123 35 Piso 6 Torre 123
Bogota D.C.; Bogota D.C; Postal Code: 1003

Contact Details: Purchase the Amgen Biotecnologica S A S report to view the information.

Basic Information
Total Employees:
Purchase the Amgen Biotecnologica S A S report to view the information.
Outstanding Shares:
Purchase the Amgen Biotecnologica S A S report to view the information.
Incorporation Date:
September 18, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Amgen Biotecnologica S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
27.5%
Total operating revenue
31.18%
Operating profit (EBIT)
22.15%
EBITDA
15.83%
Net Profit (Loss) for the Period
11.11%
Total assets
23.85%
Total equity
9%
Operating Profit Margin (ROS)
-0.21%
Net Profit Margin
-0.39%
Return on Equity (ROE)
0.14%
Debt to Equity Ratio
0.09%
Quick Ratio
-0.22%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?